CTLA4 and neoplasm: CTLA‐4 blockade in mice bearing inoculated tumors enhances anti‐tumor T‐cell responses resulting in tumor rejection (Leach et al, 1996), illustrating that releasing the brake on T cells might be an interesting strategy to combat cancer.